Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam.
Pham VL, Le TA, Pham CP, Hoa Nguyen TT, Do AT, Nguyen TK, Nguyen MH, Thu Hoang TA, Hao Vuong DT, Tam Nguyen DN, Khiem Dang V, Nguyen TO, Trang Vo TH, Do HK, Vu HT, Nguyen TTH, Pham VT, Trinh LH, Dung Nguyen K, Nguyen HG, Truong CM, Chau Pham TM, Nguyen TBP.
Pham VL, et al. Among authors: nguyen hg.
Ther Adv Med Oncol. 2024 May 9;16:17588359241242972. doi: 10.1177/17588359241242972. eCollection 2024.
Ther Adv Med Oncol. 2024.
PMID: 38736554
Free PMC article.